patients with atrial fibrillation and preserved left ventricular ejection fraction research hub

SPironolactONe for the maintenance of Sinus Rhythm in hypertensive patients with atrial fibrillation and preserved left ventricular ejection fraction: a Prospective Randomized Open Blinded End-point (PROBE) multicenter study (SPONSoR study).

This study looks at whether a medicine called spironolactone can help people with high blood pressure and an irregular heartbeat (atrial fibrillation) stay in a normal heart rhythm. It checks how well spironolactone works over 12 months in preventing their irregular heartbeat from coming back.